PW MEDTECH GROUP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.07 HKD | +4.90% |
|
+1.90% | +30.49% |
| Jul. 02 | NEEQ Accepts PW Medtech Group Subsidiary's Listing Application | MT |
| Jun. 04 | Hong Kong Stocks Rise Marginally Amid Signs of Stability in Property Sector; QuantumPharm Launches Hong Kong IPO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
PW Medtech Group Ltd is a company principally engaged in the research and development (R&D) and sales of medical devices. The Company operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The Company mainly operates its businesses in the domestic market.
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +30.49% | 204M | |
| +11.74% | 28.08B | |
| +25.93% | 2.46B | |
| +16.57% | 2.43B | |
| -49.28% | 2.23B | |
| -33.88% | 1.98B | |
| +32.22% | 2.02B | |
| -24.65% | 1.58B | |
| +10.12% | 1.35B | |
| +32.97% | 1.33B |
- Stock Market
- Equities
- 1358 Stock
- News PW Medtech Group Limited
- PW Medtech to Repurchase Shares For Up to HK$150 Million; Shares Up 10%
